Castagnetti G - Search Results

1

Combination treatment in M1 prostate cancer.

Ferrari P, Castagnetti G, Ferrari G, Pollastri CA, Tavoni F, Dotti A. Ferrari P, et al. Among authors: castagnetti g. Cancer. 1993 Dec 15;72(12 Suppl):3880-5. doi: 10.1002/1097-0142(19931215)72:12+<3880::aid-cncr2820721724>3.0.co;2-4. Cancer. 1993. PMID: 8252509 Clinical Trial.

2

Chemoimmunotherapy for prophylaxis of recurrence in superficial bladder cancer: interferon-alpha 2b versus interferon-alpha 2b with epirubicin.

Ferrari P, Castagnetti G, Pollastri CA, Ferrari G, Tavoni F, Grassi D. Ferrari P, et al. Among authors: castagnetti g. Anticancer Drugs. 1992 May;3 Suppl 1:25-7. doi: 10.1097/00001813-199205000-00006. Anticancer Drugs. 1992. PMID: 1611113 Clinical Trial.

3

Combination treatment versus LHRH alone in advanced prostatic cancer.

Ferrari P, Castagnetti G, Ferrari G, Baisi B, Dotti A. Ferrari P, et al. Among authors: castagnetti g. Urol Int. 1996;56 Suppl 1:13-7. doi: 10.1159/000282863. Urol Int. 1996. PMID: 8776812 Clinical Trial.

4

Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer.

Frassoldati A, Federico M, Barbieri F, Brausi M, Pollastri C, Berri G, Castagnetti G, Palladini PP, Silingardi V. Frassoldati A, et al. Among authors: castagnetti g. Med Oncol Tumor Pharmacother. 1991;8(2):99-103. doi: 10.1007/BF02988861. Med Oncol Tumor Pharmacother. 1991. PMID: 1749307

5

Neoplastic thrombosis in the renal cancer.

Ferrari P, Grassi D, Castagnetti G, Pollastri CA, Ferrari G. Ferrari P, et al. Among authors: castagnetti g. Eur Urol. 1990;17(1):27-9. doi: 10.1159/000463994. Eur Urol. 1990. PMID: 2318235

6

Expression of p53 and bcl-2 in clinically localized prostate cancer before and after neo-adjuvant hormonal therapy.

Cesinaro AM, Migaldi M, Ferrari G, Castagnetti G, Dotti A, De Gaetani C, Ferrari P, Trentini GP. Cesinaro AM, et al. Among authors: castagnetti g. Oncol Res. 2000;12(1):43-9. doi: 10.3727/000000001108747435. Oncol Res. 2000. PMID: 11061345 Free article.

7

Apoptosis in prostate carcinoma before and after neoadjuvant therapy with LH-RH analog.

Bencini S, Migaldi M, Castagnetti G, Pincelli C, Ferrari P, De Gaetani C, Trentini GP. Bencini S, et al. Among authors: castagnetti g. Ann N Y Acad Sci. 2003 Dec;1010:789-92. doi: 10.1196/annals.1299.142. Ann N Y Acad Sci. 2003. PMID: 15033829

8

[Ultrasound and color Doppler in the diagnosis of vasculogenic impotence].

Ferrari G, Talia B, Castagnetti G, Ferrari P. Ferrari G, et al. Among authors: castagnetti g. Arch Ital Urol Nefrol Androl. 1992 Jun;64 Suppl 2:97-101. Arch Ital Urol Nefrol Androl. 1992. PMID: 1411606 Italian.

9

Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?

Brausi M, Castagnetti G, Dotti A, De Luca G, Olmi R, Cesinaro AM. Brausi M, et al. Among authors: castagnetti g. J Urol. 2004 Sep;172(3):906-8; discussion 908-9. doi: 10.1097/01.ju.0000134622.54235.93. J Urol. 2004. PMID: 15310995

10

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Bettuzzi S, et al. Among authors: castagnetti g. Cancer Res. 2006 Jan 15;66(2):1234-40. doi: 10.1158/0008-5472.CAN-05-1145. Cancer Res. 2006. PMID: 16424063 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters